ROS-responsive glucosylated nanodisc prodrug for efficient targeted epilepsy therapy
Chemical Engineering Journal · 2026-06 · 537 · 175927
DOI: 10.1016/j.cej.2026.175927 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Engineering Journal, 2026-06. Verfasst von Yang-Qing He und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Key Technology Research and Development Program of Shandong Province, Taishan Scholar Project of Shandong Province, Chinese Chemical Society.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Key Technology Research and Development Program of Shandong Province
- Taishan Scholar Project of Shandong Province
- Chinese Chemical Society
- National Natural Science Foundation of China
Zitieren
APA
He, Y., Guo, P., Hao, Q., Wu, Z., & Han, H. (2026). ROS-responsive glucosylated nanodisc prodrug for efficient targeted epilepsy therapy. Chemical Engineering Journal, 537, 175927. https://doi.org/10.1016/j.cej.2026.175927
Vancouver
He Y, Guo P, Hao Q, Wu Z, Han H. ROS-responsive glucosylated nanodisc prodrug for efficient targeted epilepsy therapy. Chemical Engineering Journal. 2026;537:175927. doi:10.1016/j.cej.2026.175927
BibTeX
@article{He2026,
author = {He, Yang-Qing and Guo, Peng and Hao, Qiu-Lian and Wu, Zhenyong and Han, Hai-Hao},
title = {ROS-responsive glucosylated nanodisc prodrug for efficient targeted epilepsy therapy},
journal = {Chemical Engineering Journal},
year = {2026},
volume = {537},
pages = {175927},
doi = {10.1016/j.cej.2026.175927}
}
EUVIMED